EC approves Incyte’s Minjuvi combo for follicular lymphoma
The European Commission (EC) has approved Incyte’s Minjuvi (tafasitamab) in conjunction with lenalidomide and rituximab for adults with relapsed or…
All articles by Gullapalli Prasanna
Gullapalli Prasanna
-
-
Alnylam plans $250m investment in Norton manufacturing facility, US
Alnylam Pharmaceuticals is set to invest $250m in the expansion of its facility in Norton, Massachusetts, US, to meet the…
-
Harbour BioMed and BMS sign multi-specific antibody collab
Harbour BioMed and Bristol Myers Squibb (BMS) have signed a multi-year, worldwide strategic partnership and licence agreement focused on multi-specific…
-
INCOG reveals $200m injectable drug expansion in Indiana
Contract development and manufacturing organisation (CDMO) INCOG BioPharma Services has announced injectable drug manufacturing expansion at its Fishers facility in…
-
LEO Pharma applies to EMA to expand Anzupgo use to adolescents
LEO Pharma has submitted an application to the European Medicines Agency (EMA) seeking to expand the label for Anzupgo (delgocitinib)…
-
SK Capital Partners supports Swixx BioPharma’s global expansion
US-based private investment company SK Capital Partners’ affiliate has agreed to invest in Swixx BioPharma to support the latter’s next…
-
FDA approves Acadia’s Daybue Stix for Rett syndrome
The US Food and Drug Administration has approved Acadia Pharmaceuticals’ Daybue Stix (trofinetide), a dye and preservative-free powder formulation of trofinetide,…
-
Sobi buys Arthrosi to expand gout treatment pipeline
Swedish Orphan Biovitrum (Sobi) has signed an agreement for the acquisition of US-based biotechnology company Arthrosi Therapeutics, a move that…
-
China’s NMPA approves Sanofi’s rare haematologic disease treatments
China’s National Medical Products Administration (NMPA) has granted approval for Sanofi’s rare haematologic disease treatments, Qfitlia (fitusiran) and Cablivi (caplacizumab),…
-
Zealand Pharma and OTR to develop metabolic disease therapeutics
Zealand Pharma and OTR Therapeutics have signed a strategic collaboration and licence agreement aimed at jointly discovering and developing therapies…